Fluocinolone acetonide (FA) extended release(Eclipse Life Sciences)

N/A

Report date: 2025/10/24 17:59:40

Base Information

Drug NameFluocinolone acetonide (FA) extended release(Eclipse Life Sciences)
Drug Alias NameEC-104(Eclipse Life Sciences)
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEclipse Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEclipse Life Sciences Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A